Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Medicus Pharma Ltd V.MDCX

Alternate Symbol(s):  MDPLF

Healthcare Biotechnology
Medicus Pharma Ltd. is a clinical stage, multi-strategy holding company focused on investing in novel life sciences and bio-technology companies through Food and Drug Administration (FDA) approved clinical trials. The Company identifies, acquires and advances relatively de-risked clinical stage assets through clinical development and commercialization. The Company is exploring to expand its... see more

Recent & Breaking News (TSXV:MDCX)

    Medicus Pharma Ltd. Announces Closing of Private Placement of Convertible Notes

    Newsfile May 3, 2024

    Canadian Investment Regulatory Organization Trade Resumption - MDCX

    Canada NewsWire April 25, 2024

    Medicus Pharma Ltd. Announces Proposed Private Placement of Convertible Notes

    Newsfile April 25, 2024

    Canadian Investment Regulatory Organization Trading Halt - MDCX

    Canada NewsWire April 25, 2024

    Medicus Pharma Ltd. Receives FDA Comments on Phase 2 Clinical Protocol to Non-Invasively Treat Basal Cell Carcinoma of the Skin

    Newsfile March 21, 2024

    Medicus Pharma Ltd. Announces Appointment of Erica Monaco as Chief Operating Officer

    Newsfile March 5, 2024

    Medicus Pharma Ltd. Publishes Phase 1 Clinical Study Report Demonstrating Safety & Tolerability in All Participants with Basal Cell Carcinoma

    Newsfile February 15, 2024

    Medicus Pharma Ltd. Announces the Filing of a Final Base Shelf Prospectus

    Newsfile January 25, 2024

    Medicus Pharma Ltd. Announces Listing on Frankfurt Stock Exchange

    Newsfile January 18, 2024

    Biotech stock reports FDA submission only 3 months after listing

    Trevor Abes  January 3, 2024

    Medicus Pharma Ltd. Submits to the FDA Phase 2 IND Clinical Protocol to Non-Invasively Treat Basal Cell Carcinoma of the Skin

    Newsfile January 3, 2024

    Holding company invests in game-changing skin cancer treatment

    Ryan Dhillon November 17, 2023

    Medicus Pharma Opens the Market

    PR Newswire October 26, 2023

    Medicus Pharma Ltd. to Ring the Toronto Stock Exchange Opening Bell on Thursday October 26th 2023; Appoints Paul A. Marchetto, MD, FACS as Chairman of the Scientific Advisory Board

    Newsfile October 25, 2023

    Medicus Pharma Ltd. Announces Appointment of Huma Qamar, MD as Chief Scientific Officer & Head of R&D Program

    Newsfile October 18, 2023

    Medicus Pharma Ltd. Announces Commencement of Trading on TSX Venture Exchange and Appointment of Seasoned Pharma Executive Barry Fishman to the Board of Directors

    Newsfile October 11, 2023

    Medicus Pharma: A holding company to supercharge your healthcare allocation

    Trevor Abes  October 11, 2023

    Medicus Pharma Ltd. Announces Closing of Business Combination

    Newsfile October 2, 2023

    Interactive Capital Partners Corporation Announces Filing of Final Non-Offering Prospectus

    Newsfile September 22, 2023